Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Titel:
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Auteur:
Raffi, François Jaeger, Hans Quiros-Roldan, Eugenia Albrecht, Helmut Belonosova, Elena Gatell, Jose M Baril, Jean-Guy Domingo, Pere Brennan, Clare Almond, Steve Min, Sherene